FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johan Maertens

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Sona Kucharíková; Johan Maertens; Nidhi Sharma; Isabel Spriet; Patrick Van Dijck; Katrien Lagrou
Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model.
Gert J Ossenkoppele; Thomas Pabst; Jakob R Passweg; Harry C Schouten; Georg Stussi; Arjan A van de Loosdrecht; Marinus van Marwijk Kooij; Kees van Montfort; Yvette van Norden; Edo Vellenga; Gregor Verhoef; Pierre W Wijermans; Bart J Biemond; Dimitri Breems; Georgine E De Greef; Okke de Weerdt; August Ferrant; Carlos Graux; C J M Halkes; Rene M Hollestein; Mels Hoogendoorn; Mojca Jongen-Lavrencic; Mark D Levin; Johan Maertens; Bob Löwenberg
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
S M G J Daenen; E W de Klerk; Adriaan W Dekker; H Demuynck; Johan Maertens; Petra Muus; Anita W Rijneveld; Harry C Schouten; A A van de Loosdrecht; Bronno van der Holt; Marinus van Marwijk Kooy; Pierre W Wijermans; R Willemze; Shulamiet Wittebol; Bart J Biemond; Dimitri A Breems; Jan J Cornelissen
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johan Maertens (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sona Kucharíková; Johan Maertens; Nidhi Sharma; Isabel Spriet; Patrick Van Dijck; Katrien Lagrou
Activities of systemically administered echinocandins against in vivo mature Candida albicans biofilms developed in a rat subcutaneous model.
Antimicrobial agents and chemotherapy 2013;57(5):2365-8.
2012: Gert J Ossenkoppele; Thomas Pabst; Jakob R Passweg; Harry C Schouten; Georg Stussi; Arjan A van de Loosdrecht; Marinus van Marwijk Kooij; Kees van Montfort; Yvette van Norden; Edo Vellenga; Gregor Verhoef; Pierre W Wijermans; Bart J Biemond; Dimitri Breems; Georgine E De Greef; Okke de Weerdt; August Ferrant; Carlos Graux; C J M Halkes; Rene M Hollestein; Mels Hoogendoorn; Mojca Jongen-Lavrencic; Mark D Levin; Johan Maertens; Bob Löwenberg
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
Blood 2012;120(24):4706-11.
2012: S M G J Daenen; E W de Klerk; Adriaan W Dekker; H Demuynck; Johan Maertens; Petra Muus; Anita W Rijneveld; Harry C Schouten; A A van de Loosdrecht; Bronno van der Holt; Marinus van Marwijk Kooy; Pierre W Wijermans; R Willemze; Shulamiet Wittebol; Bart J Biemond; Dimitri A Breems; Jan J Cornelissen
Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON.
Leukemia 2012;26(7):1726-9.
2012: Jan J Cornelissen; Alois A Gratwohl; Berna Beverloo; Bart J Biemond; Dimitri Breems; Johan Maertens; Gert J Ossenkoppele; Thomas Pabst; Jakob R Passweg; Marinus van Marwijk Kooy; Wim L J van Putten; Edo Vellenga; Leo F Verdonck; Pierre W Wijermans; Bob Löwenberg
Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(17):2140-6.
2012: Thomas Pabst; Jakob Passweg; Harry C Schouten; Peter Sonneveld; Matthias Theobald; Wim van Putten; Marie-Christiane Vekemans; Edo Vellenga; Leo Verdonck; Mario Bargetzi; Bart Biemond; Carlos Graux; Emanuel Jacky; Marie-Cecile Legdeur; Bob Löwenberg; Johan Maertens; Gert Jan Ossenkoppele
Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.
Blood 2012;119(23):5367-73.
2012: Jorien D'Haese; Katrien Lagrou; Liesbet Lammertijn; Philippe Meersseman; Wouter Meersseman; Hélène Schoemans; Koen Theunissen; Edith Vermeulen; Greet De Vlieger; Johan Maertens
Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
Journal of clinical microbiology 2012;50(4):1258-63.
2012: Olivier Gheysens; Paul Herijgers; Marie-Christine Herregods; Nele Lips; Johan Maertens; Steven Pans; Willy E Peetermans; Tom Adriaenssens; Luc Mortelmans
Septic pulmonary embolisms and metastatic infections from methicillin-resistant Staphylococcus aureus endocarditis on FDG PET/CT.
European journal of nuclear medicine and molecular imaging 2012;39(1):183.
2011: Anita W Rijneveld; F M Spoelstra; Bronno van der Holt; Pierre W Wijermans; Rein Willemze; Shulamiet Wittebol; Bart J Biemond; Jan J Cornelissen; S M G J Daenen; Okke de Weerdt; Adriaan W Dekker; H Demuynck; M C J C Legdeur; Johan Maertens; V Mattijssen; Petra Muus; G J Ossenkoppele
Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40.
Leukemia 2011;25(11):1697-703.
2011: Karolien Anne Beel; Jan Lemmens; Johan Maertens; Hilde Vranckx; Peter Vandenberghe
CML with e6a2 BCR-ABL1 transcript: an aggressive entity?
Annals of hematology 2011;90(10):1241-3.
2011: Oliver A Cornely; Emma Dellow; Ramin Ebrahimi; Raoul Herbrecht; Johan Maertens; Mark Bresnik; J Peter Donnelly
Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
Mycoses 2011;54(5):e449-55.
2011: Marianne Paesmans; Bernardo Rapoport; Kenneth Rolston; Mickael Aoun; Augustin Ferrant; Aspasia Georgala; Jean Klastersky; Johan Maertens; Frédérique Muanza; Lieveke ameye
Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(7):1001-8.
2011: Bob Löwenberg; Thomas Pabst; Edo Vellenga; Wim L J van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Bart J Biemond; Alois Gratwohl; Georgine E De Greef; Leo F Verdonck; M Ronald Schaafsma; Michael Gregor; Matthias Theobald; Urs Schanz; Johan Maertens; Gert Ossenkoppele
Cytarabine dose for acute myeloid leukemia.
The New England journal of medicine 2011;364(11):1027-36.
2011: Johan Maertens; Andreas H Groll; Catherine Cordonnier; Rafael de La Cámara; Emmanuel Roilides; Oscar Marchetti
Treatment and timing in invasive mould disease.
The Journal of antimicrobial chemotherapy 2011;66 Suppl 1():i37-43.
2010: Johan Maertens; Jenny Bryan
Managing invasive fungal disease in immunocompromised patients.
Future microbiology 2010;5(12):1775-9.
2010: Veroniek Saegeman; Johan Maertens; Wouter Meersseman; Isabel Spriet; Erik Verbeken; Katrien Lagrou
Increasing incidence of mucormycosis in University Hospital, Belgium.
Emerging infectious diseases 2010;16(9):1456-8.
2010: Johan Maertens
Discussion of case reports.
Mycoses 2010;53 Suppl 2():16-8.
2010: Johan Maertens; Kristof Cuppens; Hélène Schoemans
Case report 1: A case of failed posaconazole prophylaxis.
Mycoses 2010;53 Suppl 2():3-5.
2010: Johan Maertens
Introduction to case reports.
Mycoses 2010;53 Suppl 2():1-2.
2010: Bob Löwenberg; Joachim Beck; Carlos Graux; Wim van Putten; Harry C Schouten; Leo F Verdonck; Augustin Ferrant; Pieter Sonneveld; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Dimitri Breems; Hilde de Muijnck; Ron Schaafsma; Gregor Verhoef; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gert Ossenkoppele; Johan Maertens
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study.
Blood 2010;115(13):2586-91.
2010: V Saegeman; Johan Maertens; N Ectors; W Meersseman; Katrien Lagrou
Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2010;48(2):245-54.
2010: M J G T Rüping; W J Heinz; A J Kindo; V Rickerts; C Lass-Flörl; C Beisel; Raoul Herbrecht; Y Roth; Gerda Silling; Andrew J Ullmann; K Borchert; Gerlinde Egerer; Johan Maertens; Georg Maschmeyer; A Simon; M Wattad; G Fischer; Jörg Vehreschild; Oliver A Cornely
Forty-one recent cases of invasive zygomycosis from a global clinical registry.
The Journal of antimicrobial chemotherapy 2010;65(2):296-302.
2010: Oliver A Cornely; Johan Maertens; M Bresnik; Andrew J Ullmann; Ramin Ebrahimi; Raoul Herbrecht
Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B.
The Journal of antimicrobial chemotherapy 2010;65(1):114-7.
2009: Johan Maertens; Vincent Maertens; Koen Theunissen; Wouter Meersseman; Philippe Meersseman; Stef Meers; Erik Verbeken; Gregor Verhoef; Johan Van Eldere; Katrien Lagrou
Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(11):1688-93.
2009: Theoklis E Zaoutis; Thomas Lehrnbecher; Andreas H Groll; William J Steinbach; Hasan Jafri; Johan Maertens; Angela L Ngai; Joseph W Chow; Arlene F Taylor; Kim M Strohmaier; Michael Bourque; Susan K Bradshaw; Maria Petrecz; Nicholas A Kartsonis
Safety experience with caspofungin in pediatric patients.
The Pediatric infectious disease journal 2009;28(12):1132-5.
2009: Jörg Vehreschild; Michal Sieniawski; Stefan Reuter; Dorothee Arenz; Dietmar Reichert; Johan Maertens; Angelika Böhme; Gerda Silling; Rodrigo Martino; Georg Maschmeyer; Maria J G T Rüping; Andrew J Ullmann; Oliver A Cornely
Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
International journal of antimicrobial agents 2009;34(5):446-50.
2009: Bob Löwenberg; Gert Ossenkoppele; Wim L J van Putten; Harry C Schouten; Carlos Graux; Augustin Ferrant; Pieter Sonneveld; Johan Maertens; Mojca Jongen-Lavrencic; Marie von Lilienfeld-Toal; Bart J Biemond; Edo Vellenga; Marinus van Marwijk Kooy; Leo F Verdonck; Joachim Beck; Hartmut Döhner; Alois Gratwohl; Thomas Pabst; Gregor Verhoef
High-dose daunorubicin in older patients with acute myeloid leukemia.
The New England journal of medicine 2009;361(13):1235-48.
2009: Philip R Roelandt; Johan Maertens; Peter Vandenberghe; Chris Verslype; Tania Roskams; Raymond Aerts; Frederik Nevens; Daan Dierickx
Hepatosplenic gammadelta T-cell lymphoma after liver transplantation: report of the first 2 cases and review of the literature.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009;15(7):686-92.
2009: Johan Maertens; Wouter Meersseman; Pascal Van Bleyenbergh
New therapies for fungal pneumonia.
Current opinion in infectious diseases 2009;22(2):183-90.
2009: Jan J Cornelissen; Bronno van der Holt; Gregor Verhoef; Mars B van't Veer; Marinus H J van Oers; Harry C Schouten; Gert Ossenkoppele; Pieter Sonneveld; Johan Maertens; Marinus van Marwijk Kooy; M Ronald Schaafsma; Pierre W Wijermans; Douwe H Biesma; Shulamiet Wittebol; Paul J Voogt; Joke W Baars; Pierre Zachée; Leo F Verdonck; Bob Löwenberg; Adriaan W Dekker
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Blood 2009;113(6):1375-82.
2009: Johan Maertens; Kristel Buvé; Koen Theunissen; Wouter Meersseman; Erik Verbeken; Gregor Verhoef; Johan Van Eldere; Katrien Lagrou
Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients.
Cancer 2009;115(2):355-62.
2008: Johan Maertens; Griet Huysmans; Koen Theunissen
Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients.
Current infectious disease reports 2008;10(6):459-65.
2008: Johan Maertens; Jenny Bryan
Recent progress in the management of invasive fungal infections in hematopoietic stem cell transplant recipients. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), March 30-April 2, 2008, Florence, Italy.
Future microbiology 2008;3(5):493-6.
2008: Johan Maertens; Jenny Bryan
Tailored treatment of invasive fungal infections.
Future microbiology 2008;3(2):129-32.
2008: Oliver A Cornely; Angelika Böhme; Dietmar Reichert; Stefan Reuter; Georg Maschmeyer; Johan Maertens; Dieter Buchheidt; Monika Paluszewska; Dorothee Arenz; Ullrich Bethe; Jenny Effelsberg; Harry Lövenich; Michal Sieniawski; Antje Haas; Hermann Einsele; Hartmut Eimermacher; Rodrigo Martino; Gerda Silling; Moritz Hahn; Sidonie Wacker; Andrew J Ullmann; Meinolf Karthaus
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis.
The Journal of antimicrobial chemotherapy 2008;61(4):939-46.
2008: Johan Maertens; Kristel Buvé; Elias Anaissie
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(2):183-9.
2008: Wouter Meersseman; Katrien Lagrou; Johan Maertens; Alexander Wilmer; Greet Hermans; Steven Vanderschueren; Isabel Spriet; Erik Verbeken; Eric Van Wijngaerden
Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
American journal of respiratory and critical care medicine 2008;177(1):27-34.
2007: Jean Klastersky; Lieveke ameye; Johan Maertens; Aspasia Georgala; Frédérique Muanza; Mickael Aoun; A Ferrant; B Rapoport; Kenneth Rolston; Marianne Paesmans
Bacteraemia in febrile neutropenic cancer patients.
International journal of antimicrobial agents 2007;30 Suppl 1():S51-9.
2007: Katrien Lagrou; Jan Verhaegen; W E Peetermans; T De Rijdt; Johan Maertens; Eric Van Wijngaerden
Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(8):541-7.
2007: Wouter Meersseman; Katrien Lagrou; Johan Maertens; Eric Van Wijngaerden
Invasive aspergillosis in the intensive care unit.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(2):205-16.
2007: Johan Maertens; Rocus R Klont; Christine Masson; Koen Theunissen; Wouter Meersseman; Katrien Lagrou; Christine Heinen; Brigitte Crépin; Johan Van Eldere; MARC TABOURET; J Peter Donnelly; Paul E Verweij
Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(10):1329-36.
2007: Oliver A Cornely; Johan Maertens; Mark Bresnik; Ramin Ebrahimi; Andrew J Ullmann; Emilio Bouza; Claus Peter Heussel; Olivier Lortholary; Christina Rieger; Angelika Boehme; Mickael Aoun; Heinz-August Horst; Anne Thiebaut; Markus Ruhnke; Dietmar Reichert; Nicola Vianelli; Stefan W Krause; Eduardo Olavarria; Raoul Herbrecht
Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(10):1289-97.
2007: Jan J Cornelissen; Wim L J van Putten; Leo F Verdonck; Matthias Theobald; Emanuel Jacky; S M G J Daenen; Marinus van Marwijk Kooy; Pierre W Wijermans; Harry Schouten; Peter C Huijgens; Hans van der Lelie; Martin Fey; Augustin Ferrant; Johan Maertens; Alois Gratwohl; Bob Lowenberg
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Blood 2007;109(9):3658-66.
2007: Johan Maertens
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
European journal of haematology 2007;78(4):275-82.
2007: Oliver A Cornely; Johan Maertens; Drew J Winston; John R Perfect; Andrew J Ullmann; THOMAS WALSH; David Helfgott; Jerzy Holowiecki; Dick Stockelberg; Yeow Tee Goh; Mario Petrini; Catherine J Hardalo; Ramachandran Suresh; David Angulo-Gonzalez
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
The New England journal of medicine 2007;356(4):348-59.
2007: Johan Maertens; Koen Theunissen; Tom Lodewyck; Katrien Lagrou; Johan Van Eldere
Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders.
Mycoses 2007;50 Suppl 1():2-17.
2006: Johan Maertens; Axel Glasmacher; Raoul Herbrecht; Anne Thiebaut; Catherine Cordonnier; Brahm H Segal; John Killar; Arlene Taylor; Nicholas A Kartsonis; Thomas Patterson; Mickael Aoun; Denis Caillot; Carole A Sable
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Cancer 2006;107(12):2888-97.
2006: Johan Maertens; Dries H Deeren; Daan Dierickx; Koen Theunissen
Preemptive antifungal therapy: still a way to go.
Current opinion in infectious diseases 2006;19(6):551-6.
2006: Rodrigo Martino; Rocio Parody; Takahiro Fukuda; Johan Maertens; Koen Theunissen; Aloysius Ho; Ghulam J Mufti; Nicolaus Kroger; Arnold R Zander; Dominik Heim; Monika Paluszewska; Dominik Selleslag; Katerina Steinerova; Per Ljungman; Simone Cesaro; Anna Nihtinen; Catherine Cordonnier; Lourdes Vazquez; Mónica López-Duarte; Javier Lopez; Rafael Cabrera; Montserrat Rovira; Stefan Neuburger; Oliver A Cornely; Ann E Hunter; Kieren Marr; Hans Jürgen Dornbusch; Hermann Einsele
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2006;108(9):2928-36.
2006: H Schoemans; Koen Theunissen; Johan Maertens; Marc Boogaerts; C Verfaillie; J Wagner
Adult umbilical cord blood transplantation: a comprehensive review.
Bone marrow transplantation 2006;38(2):83-93.
2006: Johan Maertens
Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis.
International journal of antimicrobial agents 2006;27(6):457-67.
2006: Robert Betts; Axel Glasmacher; Johan Maertens; Georg Maschmeyer; Jose A Vazquez; Hedy Teppler; Arlene Taylor; Robert J Lupinacci; Carole A Sable; Nicholas A Kartsonis
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients.
Cancer 2006;106(2):466-73.
2006: Stefan Janssens; Christophe Dubois; Jan Bogaert; Koen Theunissen; Christophe M Deroose; Walter Desmet; Maria Kalantzi; Lieven Herbots; Peter Sinnaeve; Joseph Dens; Johan Maertens; Frank E Rademakers; Steven Dymarkowski; Olivier Gheysens; Johan Van Cleemput; Guy Bormans; Johan Nuyts; Ann Belmans; Luc Mortelmans; Marc Boogaerts; Frans Van de Werf
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Lancet 2006;367(9505):113-21.
2005: Wim A Wuyts; Helmut Molzahn; Johan Maertens; Eric K Verbeken; Katrien Lagrou; Lieven J Dupont; Geert M Verleden
Fatal Scopulariopsis infection in a lung transplant recipient: a case report.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(12):2301-4.
2005: Johan Maertens; Koen Theunissen; Gregor Verhoef; Johny Verschakelen; Katrien Lagrou; Erik Verbeken; Alexander Wilmer; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(9):1242-50.
2005: Johan Maertens; Marc Boogaerts
The place for itraconazole in treatment.
The Journal of antimicrobial chemotherapy 2005;56 Suppl 1():i33-i38.
2005: Katrien Lagrou; Caroline Massonet; Koen Theunissen; Wouter Meersseman; Marc Lontie; Erik Verbeken; Johan Van Eldere; Johan Maertens
Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata.
Journal of medical microbiology 2005;54(Pt 7):685-8.
2005: Johan Maertens; Axel Glasmacher; Dominik Selleslag; Angela Ngai; Desmond Ryan; Melissa Layton; Arlene Taylor; Carole A Sable; Nicholas A Kartsonis
Evaluation of serum sandwich enzyme-linked immunosorbent assay for circulating galactomannan during caspofungin therapy: results from the caspofungin invasive aspergillosis study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(1):e9-14.
2005: Rodrigo Martino; Stéphane Bretagne; Hermann Einsele; Johan Maertens; Andrew J Ullmann; Rocio Parody; Ulrike Schumacher; Cécile Pautas; Koen Theunissen; Christine Schindel; Carmen Muñoz; Nuria Margall; Catherine Cordonnier
Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(1):67-78.
2004: Johan Maertens; Issam Raad; George Petrikkos; Marc Boogaerts; Dominik Selleslag; Finn B Petersen; Carole A Sable; Nicholas A Kartsonis; Angela Ngai; Arlene Taylor; Thomas Patterson; David W Denning; THOMAS WALSH
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1563-71.
2004: THOMAS WALSH; Hedy Teppler; Gerald R Donowitz; Johan Maertens; Lindsey R Baden; Anna Dmoszynska; Oliver A Cornely; Michael R Bourque; Robert J Lupinacci; Carole A Sable; Ben E dePauw
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
The New England journal of medicine 2004;351(14):1391-402.
2004: Johan Maertens; Koen Theunissen; Erik Verbeken; Katrien Lagrou; Jan Verhaegen; Marc Boogaerts; Johan Van Eldere
Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.
British journal of haematology 2004;126(6):852-60.
2004: Johan Maertens; Koen Theunissen; Gregor Verhoef; Johan Van Eldere
False-positive Aspergillus galactomannan antigen test results.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(2):289-90.
2004: Johan Maertens
History of the development of azole derivatives.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10 Suppl 1():1-10.
2003: Jan J Cornelissen; Bronno van der Holt; Eefke J Petersen; Lars Vindelov; Charlotte A Russel; Martin Höglund; Johan Maertens; Harry C Schouten; Eric Braakman; Monique M C Steijaert; Mark J M Zijlmans; Ineke Slaper-Cortenbach; Marc Boogaerts; Bob Löwenberg; Leo F Verdonck
A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.
Experimental hematology 2003;31(10):855-64.
2003: Karoline Spaepen; Sigrid Stroobants; Patrick Dupont; Peter Vandenberghe; Johan Maertens; Guy Bormans; José Thomas; Jan Balzarini; Christiane De Wolf-Peeters; Luc Mortelmans; Gregor Verhoef
Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation.
Blood 2003;102(1):53-9.
2003: Johan Maertens; Marc Boogaerts
Caspofungin in the treatment of candidosis and aspergillosis.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2003;7(2):94-101.
2002: Johan Maertens; Johan Van Eldere; Jan Verhaegen; Erik Verbeken; Johny Verschakelen; Marc Boogaerts
Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.
The Journal of infectious diseases 2002;186(9):1297-306.
2002: S Ascioglu; John H Rex; Ben E de Pauw; JOHN BENNETT; J Bille; F Crokaert; David W Denning; J Peter Donnelly; John Edwards; Z Erjavec; D Fiere; Olivier Lortholary; Johan Maertens; Jacques Meis; Thomas Patterson; J Ritter; Dominik Selleslag; P M Shah; D A Stevens; THOMAS WALSH
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(1):7-14.
2001: Marc Boogaerts; Johan Maertens; Achiel Van Hoof; Robrecht De Bock; G Fillet; Marc Peetermans; Dominik Selleslag; B Vandercam; Koenraad H Vandewoude; Pierre Zachée; K De Beule
Itraconazole versus amphotericin B plus nystatin in the prophylaxis of fungal infections in neutropenic cancer patients.
The Journal of antimicrobial chemotherapy 2001;48(1):97-103.
2001: Johan Maertens; Jan Verhaegen; Katrien Lagrou; Johan Van Eldere; Marc Boogaerts
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.
Blood 2001;97(6):1604-10.
2001: Marc Boogaerts; Johan Maertens; R Van Der Geest; André Bosly; J M Michaux; Achiel Van Hoof; M Cleeren; R Wostenborghs; K De Beule
Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
Antimicrobial agents and chemotherapy 2001;45(3):981-5.
2001: Johan Maertens; M Delforge; P Vandenberghe; M Boogaerts; J Verhaegen
Catheter-related bacteremia due to Ewingella americana.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(2):103-4.
2001: Marc Boogaerts; Johan Maertens
Clinical experience with itraconazole in systemic fungal infections.
Drugs 2001;61 Suppl 1():39-47.
2000: Rodrigo Martino; Johan Maertens; Stéphane Bretagne; Montserrat Rovira; Eric DECONINCK; A J Ullmann; T Held; C Cordonnier
Toxoplasmosis after hematopoietic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;31(5):1188-95.
2000: Johan Maertens; Katrien Lagrou; H Deweerdt; I Surmont; Gregor Verhoef; Jan Verhaegen; Marc Boogaerts
Disseminated infection by Scedosporium prolificans: an emerging fatality among haematology patients. Case report and review.
Annals of hematology 2000;79(6):340-4.
2000: R J Lories; Johan Maertens; Jan L Ceuppens; Willy E Peetermans
The use of polyclonal intravenous immunoglobulins in the prevention and treatment of infectious diseases.
Acta clinica Belgica 2000;55(3):163-9.
2000: R Martino; Stéphane Bretagne; M Rovira; A J Ullmann; Johan Maertens; T Held; Eric DECONINCK; C Cordonnier
Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 2000;25(10):1111-4.
2000: Johan Maertens; M A Boogaerts
Fungal cell wall inhibitors: emphasis on clinical aspects.
Current pharmaceutical design 2000;6(2):225-39.
1999: Johan Maertens; M A Boogaerts
Antifungal prophylaxis in neutropenia.
Current opinion in infectious diseases 1999;12(6):549-55.
1999: Johan Maertens; Jan Verhaegen; Hilde Demuynck; P Brock; Gregor Verhoef; Peter Vandenberghe; Johan Van Eldere; Lieve Verbist; Marc Boogaerts
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.
Journal of clinical microbiology 1999;37(10):3223-8.
1999: Johan Maertens; Hilde Demuynck; Eric K Verbeken; Pierre Zachée; Gregor Verhoef; Peter Vandenberghe; Marc Boogaerts
Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis.
Bone marrow transplantation 1999;24(3):307-12.
1999: Johan Maertens
Sch-27899 (Schering-Plough Corp).
IDrugs : the investigational drugs journal 1999;2(5):446-53.
1998: Michel Delforge; Hilde Demuynck; Gregor Verhoef; Peter Vandenberghe; Pierre Zachée; Johan Maertens; Victor Van Duppen; Marc Boogaerts
Patients with high-risk myelodysplastic syndrome can have polyclonal or clonal haemopoiesis in complete haematological remission.
British journal of haematology 1998;102(2):486-94.
1998: Johan Maertens; M A Boogaerts
Anti-infective strategies in neutropenic patients.
Acta clinica Belgica 1998;53(3):168-77.
1997: Gregor Verhoef; Hilde Demuynck; Michel Delforge; Peter Vandenberghe; Johan Maertens; Pierre Zachée; Marc Boogaerts
Autologous peripheral blood progenitor cell transplantation in patients with high-risk myelodysplastic syndromes.
Pathologie-biologie 1997;45(8):651-5.